NVS - Why Is Kidney Disease-Focused Alpine Immune Sciences Stock Trading Higher On Wednesday? | Benzinga
Alpine Immune Sciences Inc (NASDAQ:ALPN) is reportedly considering strategic options, including a potential sale, following interest from potential buyers.
The Seattle-based firm is working closely with advisors and evaluating various possibilities, and at least one major pharmaceutical player has expressed interest in an acquisition.
While discussions are ongoing, Bloomberg cautioned, citing sources familiar with the matter, that no decision has been made, and there’s no assurance that Alpine Immune will indeed pursue a sale.
Over the past year, Alpine Immune stock has surged ...